🇺🇸 FDA
Pipeline program

ALN-AGT01 RVR

ALN-AGT01 RVR-002

Phase 2 small_molecule active

Quick answer

ALN-AGT01 RVR for Hypertension is a Phase 2 program (small_molecule) at ALNYLAM PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
ALNYLAM PHARMACEUTICALS, INC.
Indication
Hypertension
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials